Low Dose ARD-501
AARD-501.2
Phase 2 small_molecule completed
Quick answer
Low Dose ARD-501 for Autism Spectrum Disorder is a Phase 2 program (small_molecule) at Aardvark Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aardvark Therapeutics
- Indication
- Autism Spectrum Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed